Nvidia Corp. will invest $1 billion over five years to establish a new artificial intelligence laboratory in collaboration with Eli Lilly & Co. The facility, located in Silicon Valley, aims to accelerate the application of AI in the pharmaceutical industry by leveraging Lilly's lab expertise.

As the new year begins, the author reflects on a more active approach to cryptocurrency trading while maintaining a lean portfolio. Highlighting the AI Agent sector and upcoming protocols like x402 and ERC-8004, they present four low-cap tokens worth researching, emphasizing the potential for gains despite the overall market's risks.

Bridgewater founder Ray Dalio cautioned that the current AI boom is in the early stages of a bubble, following significant gains in Wall Street's technology stocks. He noted that while the Federal Reserve may lower interest rates, investors are beginning to seek opportunities beyond highly valued tech stocks due to concerns over potential overvaluation.